As of Nov 15, 2024, Johnson & Johnson's fair value using the Peter Lynch formula is ($58.0) per share. The current price of $154.0 suggests Johnson & Johnson may be overvalued by this metric.
As of Nov 15, 2024, Johnson & Johnson's P/E ratio is 25.2x. This is calculated by dividing the current share price of $154.0 by the Earnings per Share (EPS) for the trailing twelve months, which is $6.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
Johnson & Johnson earnings per share (EPS) for the twelve months ending Nov 15, 2024, was $6.1, a (12.7%) growth year-over-year.